CClinicalTrials.gg
CompletedNCT06215339Updated Jan 22, 2024

Diet Therapy in Hemodialysis Patients

An interventional study of diet therapy training in Hemolysis, Diet and Symptoms and Signs, sponsored by Dilan aktepe coşar. Completed at 1 site in Turkey. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-22.

Sponsored by Dilan aktepe coşar · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled May 2023, registered Dec 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study determined the effect of dietary education given to hemodialysis patients on dietary treatment and symptoms.

Read the detailed description

Diet therapy is a part of the treatment of hemodialysis patients. In order for the treatment to be effective, it is necessary to comply with the diet. Non-compliance with diet treatment affects the symptoms experienced by the patient, resulting in morbidity, low quality of life and mortality. Knowing patients' compliance with diet therapy is important in ensuring symptom control. The aim of this study is to determine the effect of diet therapy on symptom management in hemodialysis patients.

02

Conditions studied

  • Hemolysis
  • Diet
  • Symptoms and Signs
  • Healthy

Browse trials for

Keywords

  • Hemolysis
  • Diet
  • Healthy
  • Symptoms and Signs
03

In context

Hemolysis

184 studies on the registry are indexed under Hemolysis; 42 are open to participants now.

This study's enrollment of 60 is above the median of 36 across 113 interventional studies indexed under Hemolysis.

Browse Hemolysis studies →

Lead sponsor

Dilan aktepe coşar is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Being ≥18 years old,

  • Agreeing to participate in the research,
  • Being literate,
  • Being able to communicate verbally,
  • Receiving outpatient HD treatment three sessions a week at the same institution,
  • No impairment in mental and cognitive functions,
  • Has been receiving HD treatment for at least three months (to be defined as a chronic HD program)

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate in the research,
  • Being on peritoneal dialysis,
  • Being diagnosed with a psychiatric disorder diagnosed by a psychiatrist,
  • The general condition (hemodynamically) is unstable (heart rate \< 100 mm/Hg or diastolic BP\< 60 mm/Hg),
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    group where diet education is given

    Patients in the experimental group were given face-to-face diet education by the researcher in the waiting room for approximately 15 minutes and an "Information Brochure" was given. Pre-training (pre-test) for hemodialysis patients Data collection tools were applied. All data collection tools were applied to these patients, except for the structured Patient Information Form for post-training measurements (intermediate measurement) 1 month after the training was given.

    Behavioral: diet therapy training

  • No intervention
    Control group

    No treatment was performed on hemodialysis patients in this group. Only data collection forms were applied to the patients before the study (pretest), at the 1st week (intermediate measurement/1st measurement) and at the end of the study. (8th week) 3 times in total for 8 weeks.

Interventions

  • Behavioraldiet therapy training

    diet education

    Also known as: Group without diet education

06

What researchers measure

Primary outcomes

  1. Hemodialysis Patients' Attitude Scale Towards Diet Therapy (HDTO)"

    "HDTÖ" (HD Dietary Attitude Scale): Each item is scored as 1-Strongly Agree, 2-Agree, 3-Disagree, 4-Strongly Disagree. The scale comprises three sub-dimensions:

    Time frame: 4 week

Secondary outcomes

  1. "Dialysis Symptom Index (DSI)"

    this scale assesses the emotional and physical symptoms of dialysis patients and the severity of these symptoms, consisting of a total of 30 items

    Time frame: 4 week

07

Study locations

1 site
  • Gümüşhane Üniversitesi
    Gümüşhane, Kelkit 2900, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06215339
Lead sponsor
Dilan aktepe coşar
Responsible party
Dilan aktepe coşar (Lecturer, Gümüşhane Universıty) — Sponsor-investigator
First posted
Jan 22, 2024
Start date
May 1, 2023
Primary completion
Jun 1, 2023
Completion
Jul 1, 2023
Last update
Jan 22, 2024

Study contacts

Dilan aktepe coşar, lecture
principal investigator · Gümüşhane Universıty

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion